MDxHealth SA (MDXH)
NASDAQ: MDXH · IEX Real-Time Price · USD
2.300
-0.070 (-2.95%)
Apr 17, 2024, 3:59 PM EDT - Market closed
MDxHealth Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.33, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 218.70% from the current stock price of 2.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
The average analyst rating for MDxHealth stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +204.35% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +247.83% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +160.87% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +204.35% | May 31, 2023 |
| BTIG | BTIG | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +204.35% | May 16, 2023 |
Financial Forecast
Revenue This Year
81.53M
from 70.19M
Increased by 16.15%
Revenue Next Year
93.11M
from 81.53M
Increased by 14.21%
EPS This Year
-1.04
from -16.60
EPS Next Year
-0.66
from -1.04
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 84.0M | 99.2M | 116.6M | 133.8M |
| Avg | 81.5M | 93.1M | 107.4M | 130.0M |
| Low | 78.2M | 85.8M | 93.3M | 124.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 19.7% | 21.7% | 25.2% | 24.5% |
| Avg | 16.1% | 14.2% | 15.4% | 21.0% |
| Low | 11.4% | 5.3% | 0.3% | 16.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.91 | -0.36 | 0.02 | 0.63 |
| Avg | -1.04 | -0.66 | -0.36 | 0.61 |
| Low | -1.14 | -0.97 | -0.75 | 0.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.